Development of a United Kingdom–centric cost-effectiveness model for denture cleaning strategies

Journal of Prosthetic Dentistry ◽

10.1016/j.prosdent.2021.10.022 ◽

2021 ◽

Author(s):

Mike Herdman ◽

Ilona Johnson ◽

Stephen Mason ◽

Christopher R. Vernazza ◽

Roshan Varghese

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Effectiveness Model

Download Full-text

936-P: Annual Cost to Achieve Cost Effectiveness of Continuous Glucose Monitoring in Hypoglycemia-Unaware Type 1 Diabetes Patients Using Intensive Insulin in the United Kingdom

Diabetes ◽

10.2337/db19-936-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 936-P

Author(s):

S. PINAR BILIR ◽

CARESSE CAMPBELL ◽

RICHARD HELLMUND ◽

JULIE MUNAKATA

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Continuous Glucose Monitoring ◽

Annual Cost ◽

Glucose Monitoring ◽

The United Kingdom ◽

Diabetes Patients

Download Full-text

A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: Patients switching within firstline agents or to Natalizumab or Fingolimod in active RRMS

10.26226/morressier.59a3eda9d462b8028d8957ad ◽

2017 ◽

Author(s):

Tim Spelman

Keyword(s):

Cost Effectiveness ◽

Comparative Effectiveness ◽

Real World Data ◽

Effectiveness Analysis ◽

Effectiveness Model ◽

Propensity Matching ◽

Comparative Effectiveness Analysis

Download Full-text

Faculty Opinions recommendation of Modelling the cost-effectiveness of human milk and breastfeeding in preterm infants in the United Kingdom.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727352908.793534182 ◽

2017 ◽

Author(s):

Jean-Ralph Zahar

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Preterm Infants ◽

The United Kingdom ◽

Download Full-text

PCN84 Preliminary Results of a Cost Effectiveness MODEL of Atezolizumab PLUS Bevacizumab in Unresectable Hepatocellular Carcinoma (HCC) in France

Value in Health ◽

10.1016/j.jval.2020.08.221 ◽

2020 ◽

Vol 23 ◽

pp. S436

Author(s):

C. Dubois de Gennes ◽

B. Mazaleyrat ◽

J. Sanchez Alvarez ◽

H. Cawston

Keyword(s):

Hepatocellular Carcinoma ◽

Cost Effectiveness ◽

Preliminary Results ◽

Unresectable Hepatocellular Carcinoma ◽

Effectiveness Model

Download Full-text

Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening

PharmacoEconomics ◽

10.1007/s40273-021-01009-6 ◽

2021 ◽

Vol 39 (5) ◽

pp. 589-600

Author(s):

Edna Keeney ◽

Howard Thom ◽

Emma Turner ◽

Richard M. Martin ◽

Sabina Sanghera

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Cancer Screening ◽

Prostate Cancer Screening ◽

Model Application ◽

Modified Delphi ◽

Delphi Approach ◽

Effectiveness Model

Download Full-text

Sample size determination for a Bayesian cost-effectiveness model with structural zero costs

Communications in Statistics - Simulation and Computation ◽

10.1080/03610918.2021.1901916 ◽

2021 ◽

pp. 1-16

Author(s):

Clay King ◽

James D. Stamey

Keyword(s):

Cost Effectiveness ◽

Sample Size ◽

Sample Size Determination ◽

Size Determination ◽

Effectiveness Model

Download Full-text

Comment on Keeney et al.’s “Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening”

PharmacoEconomics ◽

10.1007/s40273-021-01061-2 ◽

2021 ◽

Author(s):

James F. O’Mahony

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Cancer Screening ◽

Prostate Cancer Screening ◽

Effectiveness Model ◽

Delphi Analysis

Download Full-text

Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

ESC Heart Failure ◽

10.1002/ehf2.13401 ◽

2021 ◽

Author(s):

Stephan Schueler ◽

Scott C. Silvestry ◽

William G. Cotts ◽

Mark S. Slaughter ◽

Wayne C. Levy ◽

...

Keyword(s):

United Kingdom ◽

Cost Effectiveness ◽

Left Ventricular ◽

Ventricular Assist Devices ◽

Destination Therapy ◽

Left Ventricular Assist Devices ◽

Ventricular Assist ◽

Assist Devices ◽

The United Kingdom ◽

Left Ventricular Assist

Download Full-text

Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom

PLoS ONE ◽

10.1371/journal.pone.0175920 ◽

2017 ◽

Vol 12 (6) ◽

pp. e0175920 ◽

Author(s):

Jordan Amdahl ◽

Jose Diaz ◽

Arati Sharma ◽

Jinhee Park ◽

David Chandiwana ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

United Kingdom ◽

Cost Effectiveness ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

The United Kingdom

Download Full-text

Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy

Value in Health ◽

10.1016/j.jval.2015.12.018 ◽

2016 ◽

Vol 19 (4) ◽

pp. 374-382 ◽

Author(s):

Ursula Becker ◽

Andrew H. Briggs ◽

Santiago G. Moreno ◽

Joshua A. Ray ◽

Phuong Ngo ◽

...

Keyword(s):

Cost Effectiveness ◽

Chronic Lymphocytic Leukemia ◽

Lymphocytic Leukemia ◽

Full Dose ◽

Effectiveness Model

Download Full-text